Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

2103 will be a busy year for ctix. We'll have multiple trials going on kevetrin along with a prurisol trial.

And, as I'm sure you are aware, it is very difficult to get into Harvards' Dana Farber. All of the data would have been thoroughly scrutinized during the qualifying process.

And, peer reviewed papers on preclinical work aren't very important once in a clinical trial.

Thanks for sharing what you come up with. ;)





In Reply to 'duelittle2'
Pfizer Eyes Kevetrin?

" Cellceutix Corp announced that it has entered into an agreement with Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, on a research project with Kevetrin. The Medical Center wishes to exploit the nuclear and/or mitochondrial pro-apoptotic function of p53 in melanoma and renal cell carcinoma, two types of cancer that are particularly resistant to therapy. The collaborative studies are completely independent from the planned clinical trials for Kevetrin that will be conducted at these cancer centers and sponsored by Cellceutix.

Harvard's researchers had to believe that Kevetrin could work in conjugation with Pfizer's multikinase inhibitors. Kevetrin had successfully demonstrated itself as extremely safe and effective in stopping, reversing, and at times curing lung, prostate, colon and breast cancer in animal trials. "........................

http://seekingalpha.com/article/802771-pfizer-eyes-kevetrin


============================

Also

http://www.medkoo.com/Anticancer-trials/Kevetrin.htm

http://www.cancer.gov/clinicaltrials/search/results?protocolsearchid=11235217

http://www.cancer.gov/clinicaltrials/search/view?cdrid=738782&version=HealthProfessional&protocolsearchid=11235217